Journal of Experimental & Clinical Cancer Research · 2021 · 25 citations · 42 references
MedicineCancer BiologyOncologyMolecular OncologyNeoplasiaOral OncologyCancer Cell SignalingOncogenic Signaling PathwaysOral CarcinogenesisRadiation BiologyRadiation CarcinogenesisRadiation TherapyCancer Cell RadiosensitivityCancer Cell Survival SignalingCellular RadiosensitivityNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B SignalingRadiotherapy For Oral CancerTumor Radiosensitivity
BACKGROUND: Ectopic insulin-like growth factor binding protein 3 (IGFBP3) expression has been shown to enhance cell migration and lymph node metastasis of oral squamous cell carcinoma (OSCC) cells. However, OSCC patients with high IGFBP3 expression had improved survival compared with those with low expression. Therefore, we speculated that IGFBP3 expression may play a role in response to conventional OSCC therapies, such as radiotherapy. METHODS: We used in vitro and in vivo analyses to explore IGFBP3-mediated radiosensitivity. Reactive oxygen species (ROS) detection by flow cytometry was used to confirm IGFBP3-mediated ionizing radiation (IR)-induced apoptosis. Geneset enrichment analysis (GSEA) and ingenuity pathway analysis (IPA) were used to analyze the relationship between IGFBP3 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling. Assays involving an NF-κB inhibitor, ROS scavenger or interleukin 6 (IL-6) were used to evaluate the NF-κB/IL-6/ROS signaling in IGFBP3-mediated radiosensitivity. RESULTS: Ectopic IGFBP3 expression enhanced IR-induced cell-killing in vitro. In vivo, IGFBP3 reduced tumor growth and increased apoptotic signals of tumor tissues in immunocompromised mice treated with IR. Combined with IR, ectopic IGFBP3 expression induced mitochondria-dependent apoptosis, which was apparent through mitochondrial destruction and increased ROS production. Ectopic IGFBP3 expression enhanced NK-κB activation and downstream cytokine expression. After IR exposure, IGFBP3-induced NF-κB activation was inhibited by the ROS scavenger N-acetyl-L-cysteine (NAC). IGFBP3-mediated ROS production was reduced by the NF-κB inhibitor BMS-345541, while exogenous IL-6 rescued the NF-κB-inhibited, IGFBP3-mediated ROS production. CONCLUSIONS: Our data demonstrate that IGFBP3, a potential biomarker for radiosensitivity, promotes IR-mediated OSCC cell death by increasing ROS production through NF-κB activation and cytokine production.
42
NF-κB signaling in inflammation
Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text
Life Sciences, Immunology, Pathology +17
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn, Robert W. Cho, Neethan A. Lobo et al. · Nature · 2009 · 2.5K citations · Full text
Medicine, Cancer Biology, Oncology +14
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
Mario Mauthe, Idil Orhon, Cecilia Rocchi et al. · Autophagy · 2018 · 2.1K citations · Full text